KCNH2 and colorectal cancer: Notably, drug repurposing represents a novel frontier for antineoplastic treatment and hERG1 and its complexes may represent a novel target, as already demonstrated by the antineoplastic effects of the antibiotic Clarithromycin in colorectal cancer.